RxDoctor Payments Data

Anupam Jayaram, MD

Ophthalmic Plastic and Reconstructive Surgery · Menlo Park, CANPI 1174803944

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,407 of the $26,094 with a category attached, or 78.2%. AbbVie accounts for 94.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $14,872 and has fallen 95.9% since, to $608 in 2025.

$26,094in general payments, 2019–2025

Across 124 payments — averaging $210.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$25K
  • Solta Medical, A Division Of Bausch Health US, LLC$586
  • Merz North America, Inc.$237
  • Aerie Pharmaceuticals, Inc.$163
  • Sun Pharmaceutical Industries Inc.$132
  • Galderma Laboratories, L.p.$122
  • plus $293 from 6 others

What the payments were for

  • Consulting fees$20,40778%
  • Travel & lodging$1,7547%
  • Food & beverage$3,93315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,094 in reported general payments places this provider in the 85th percentile of 50 ophthalmic plastic and reconstructive surgery providers in California.

See all ophthalmic plastic and reconstructive surgery providers in California

Medicare billing

Part B allowed, 2024
$12,126
Medicare patients
30
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmic plastic and reconstructive surgery in Menlo Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →